Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.
Cardiovasc Diabetol
; 17(1): 20, 2018 01 24.
Article
in En
| MEDLINE
| ID: mdl-29368615
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cardiovascular Diseases
/
Thiazolidinediones
/
Diabetes Mellitus, Type 2
/
Glycoside Hydrolase Inhibitors
/
Hypoglycemic Agents
/
Metformin
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Cardiovasc Diabetol
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
ENDOCRINOLOGIA
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: